Market Overview

Stocks Hitting 52-Week Lows

Share:
Related MDCO
Earnings Scheduled For February 17, 2016
The Medicines Company Appoints Sarissa Capital Management Exec To Its Board Of Directors
Related NRX
Here's Why NephroGenex Plunged 40% On Wednesday
Mid-Morning Market Update: Markets Open Higher; General Electric Profit Beats Views
Exploring Graham's Net-Net Working Capital Strategy (Seeking Alpha)

The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

NephroGenex (NASDAQ: NRX) shares reached a new 52-week low of $6.67. On Monday, NephroGenex posted a full-year net loss of $6.3 million, or $19.71 per share.

Bio-Path Holdings (NASDAQ: BPTH) shares declined 5.66% to touch a new 52-week low of $2.50. Bio-Path shares have jumped 349.15% over the past 52 weeks, while the S&P 500 index has gained 19.24% in the same period.

Akers Biosciences (NASDAQ: AKER) shares reached a new 52-week low of $3.85. Akers Biosciences' trailing-twelve-month ROE is -41.12%.

Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

 

Related Articles (BPTH + AKER)

View Comments and Join the Discussion!